SUBSEQUENT EVENTS (Narrative) (Details) - USD ($)	1 Months Ended
	Jul. 27, 2016	Jan. 25, 2016	Jun. 30, 2016	[1],[2],[3]	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Subsequent Event [Line Items]
Stock Issued During Period, Shares, New Issues		2,618
Class of Warrant or Right, Outstanding			10,236,621		16,634,778	13,674,409	10,653,469
Subsequent Event [Member]
Subsequent Event [Line Items]
Fair Value of Warrants	$ 3,058,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1.00
Warrants to Purchase of Common Stock	1.141
Warrant Expiration Term	5 years 6 months
Warrant Exercise Rights, Maximum Beneficial Ownership Percentage On Common Stock	4.99%
Warrant Exercise Right, Maximum Limitation Percentage	9.99%
Class Of Warrants Or Right ,Terminated	5,500,000
Share Price	$ 1.15
Subsequent Event [Member] | Minimum [Member]
Subsequent Event [Line Items]
Class Of Warrant Or Right Terminated,Exercise Price	1.21
Subsequent Event [Member] | Maximum [Member]
Subsequent Event [Line Items]
Class Of Warrant Or Right Terminated,Exercise Price	1.25
Subsequent Event [Member] | July Offering [Member]
Subsequent Event [Line Items]
Shares Issued, Price Per Share	$ 0.81
Fair Value of Warrants	$ 858,000
Sale of Stock, Consideration Received on Transaction	$ 5,000,000
Subsequent Event [Member] | July Offering [Member] | Common Stock [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, New Issues	6,172,840
Subsequent Event [Member] | July Offering [Member] | Warrant [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, New Issues	7,043,211
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	1,543,210
Class of Warrant or Right, Outstanding	5,500,001

[1] Excludes the Crede Tranche 2 and Tranche 3 warrants to purchase 2,000,000 shares of common stock because the warrants will never be exercisable (see Note 4 for additional discussion).

[2] Includes warrants to purchase 312,730 shares of common stock (3.1%) held by a former officer and director that have had the anti-dilution feature removed.

[3] Includes warrants to purchase 533,000 shares of common stock (5.2%) held by officers and directors that have had the anti-dilution feature removed.